|
| |
| | | 69322 | | 04.03.2024 | | Amgen Switzerland AG | | | | | | | 03.03.2029 | | | | | | | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Uplizna 100 mg/10ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Inebilizumabum 100mg / 10ml) | L04AA47 | |
|
|
|
